| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
Market |
Healthcare and Medical |
Report Type |
Market Research |
Country |
Global |
Published |
26 January 2010 |
Number of Pages |
0 |
- |
|
Publisher |
Datamonitor |
The report expects antidiabetic therapies to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2018. A large and diverse development pipeline will provide a number of new blockbuster drugs but the heavy genericization of the hypertension and dyslipidemia primary care markets will lead to the overall market only growing by 0.9% in the seven major markets.
Reasons to Purchase
*Qualify and quantify the Top 10 cardiovascular therapy brands across the seven major pharmaceutical markets from 2008 to 2018.
*Understand key drivers and predict the future performance of leading products.
*Assess the remaining market opportunities, where established therapies and other developmental compounds fail to address key unmet clinical needs.
Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.